Viemed Healthcare Net Income
| VMD Stock | USD 8.29 0.16 1.89% |
As of the 11th of February 2026, Viemed Healthcare has the Coefficient Of Variation of 490.56, risk adjusted performance of 0.1692, and Semi Deviation of 1.21. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viemed Healthcare, as well as the relationship between them. Please validate Viemed Healthcare information ratio, as well as the relationship between the value at risk and expected short fall to decide if Viemed Healthcare is priced more or less accurately, providing market reflects its prevalent price of 8.29 per share. Given that Viemed Healthcare has jensen alpha of 0.347, we advise you to double-check Viemed Healthcare's current market performance to make sure the company can sustain itself at a future point.
Viemed Healthcare Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.3462 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 13.1 M | 11.5 M | |
| Net Income From Continuing Ops | 13.1 M | 11.6 M | |
| Net Income Applicable To Common Shares | 7.2 M | 11.6 M | |
| Net Income Per Share | 0.33 | 0.56 | |
| Net Income Per E B T | 0.80 | 0.76 |
Viemed | Net Income | Build AI portfolio with Viemed Stock |
Analyzing Viemed Healthcare's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Viemed Healthcare's current valuation and future prospects.
Latest Viemed Healthcare's Net Income Growth Pattern
Below is the plot of the Net Income of Viemed Healthcare over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Viemed Healthcare financial statement analysis. It represents the amount of money remaining after all of Viemed Healthcare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Viemed Healthcare's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Viemed Healthcare's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 11.41 M | 10 Years Trend |
|
Net Income |
| Timeline |
Viemed Net Income Regression Statistics
| Arithmetic Mean | 10,419,197 | |
| Geometric Mean | 9,041,835 | |
| Coefficient Of Variation | 57.45 | |
| Mean Deviation | 3,007,082 | |
| Median | 9,453,000 | |
| Standard Deviation | 5,986,030 | |
| Sample Variance | 35.8T | |
| Range | 30.3M | |
| R-Value | 0.22 | |
| Mean Square Error | 36.4T | |
| R-Squared | 0.05 | |
| Significance | 0.41 | |
| Slope | 255,473 | |
| Total Sum of Squares | 573.3T |
Viemed Net Income History
Other Fundumenentals of Viemed Healthcare
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Viemed Healthcare Net Income component correlations
Viemed Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Viemed Healthcare is extremely important. It helps to project a fair market value of Viemed Stock properly, considering its historical fundamentals such as Net Income. Since Viemed Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Viemed Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Viemed Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Viemed diversify its offerings? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Viemed Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.1) | Earnings Share 0.34 | Revenue Per Share | Quarterly Revenue Growth 0.24 | Return On Assets |
Viemed Healthcare's market price often diverges from its book value, the accounting figure shown on Viemed's balance sheet. Smart investors calculate Viemed Healthcare's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Viemed Healthcare's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Viemed Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Viemed Healthcare's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Viemed Healthcare.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Viemed Healthcare on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Viemed Healthcare or generate 0.0% return on investment in Viemed Healthcare over 90 days. Viemed Healthcare is related to or competes with Inspira Technologies, Tenon Medical, Biomerica, Heart Test, STRATA Skin, Aptevo Therapeutics, and Advanced Biomed. Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory... More
Viemed Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Viemed Healthcare's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Viemed Healthcare upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.6 | |||
| Information Ratio | 0.1572 | |||
| Maximum Drawdown | 8.29 | |||
| Value At Risk | (2.64) | |||
| Potential Upside | 4.3 |
Viemed Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viemed Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Viemed Healthcare's standard deviation. In reality, there are many statistical measures that can use Viemed Healthcare historical prices to predict the future Viemed Healthcare's volatility.| Risk Adjusted Performance | 0.1692 | |||
| Jensen Alpha | 0.347 | |||
| Total Risk Alpha | 0.1899 | |||
| Sortino Ratio | 0.1951 | |||
| Treynor Ratio | 0.6806 |
Viemed Healthcare February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1692 | |||
| Market Risk Adjusted Performance | 0.6906 | |||
| Mean Deviation | 1.54 | |||
| Semi Deviation | 1.21 | |||
| Downside Deviation | 1.6 | |||
| Coefficient Of Variation | 490.56 | |||
| Standard Deviation | 1.99 | |||
| Variance | 3.95 | |||
| Information Ratio | 0.1572 | |||
| Jensen Alpha | 0.347 | |||
| Total Risk Alpha | 0.1899 | |||
| Sortino Ratio | 0.1951 | |||
| Treynor Ratio | 0.6806 | |||
| Maximum Drawdown | 8.29 | |||
| Value At Risk | (2.64) | |||
| Potential Upside | 4.3 | |||
| Downside Variance | 2.56 | |||
| Semi Variance | 1.46 | |||
| Expected Short fall | (1.82) | |||
| Skewness | 0.6452 | |||
| Kurtosis | 0.384 |
Viemed Healthcare Backtested Returns
Viemed Healthcare appears to be not too volatile, given 3 months investment horizon. Viemed Healthcare owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.23, which indicates the firm had a 0.23 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Viemed Healthcare, which you can use to evaluate the volatility of the company. Please review Viemed Healthcare's Risk Adjusted Performance of 0.1692, semi deviation of 1.21, and Coefficient Of Variation of 490.56 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Viemed Healthcare holds a performance score of 18. The entity has a beta of 0.58, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Viemed Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Viemed Healthcare is expected to be smaller as well. Please check Viemed Healthcare's total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Viemed Healthcare's existing price patterns will revert.
Auto-correlation | 0.60 |
Good predictability
Viemed Healthcare has good predictability. Overlapping area represents the amount of predictability between Viemed Healthcare time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Viemed Healthcare price movement. The serial correlation of 0.6 indicates that roughly 60.0% of current Viemed Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.6 | |
| Spearman Rank Test | 0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 0.18 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Viemed Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Viemed Healthcare reported net income of 11.41 M. This is 96.66% lower than that of the Health Care Equipment & Supplies sector and 95.21% lower than that of the Health Care industry. The net income for all United States stocks is 98.0% higher than that of the company.
Viemed Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Viemed Healthcare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Viemed Healthcare could also be used in its relative valuation, which is a method of valuing Viemed Healthcare by comparing valuation metrics of similar companies.Viemed Healthcare is currently under evaluation in net income category among its peers.
Viemed Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Viemed Healthcare from analyzing Viemed Healthcare's financial statements. These drivers represent accounts that assess Viemed Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Viemed Healthcare's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 300.6M | 206.1M | 292.2M | 301.1M | 271.0M | 144.4M | |
| Enterprise Value | 280.8M | 184.3M | 276.0M | 298.6M | 268.7M | 139.4M |
Viemed Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Viemed Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Viemed Healthcare's managers, analysts, and investors.Environmental | Governance | Social |
Viemed Healthcare Institutional Holders
Institutional Holdings refers to the ownership stake in Viemed Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Viemed Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Viemed Healthcare's value.| Shares | Arnhold & S. Bleichroeder Advisers, Llc | 2025-06-30 | 455.3 K | Tocqueville Asset Management L.p. | 2025-06-30 | 417.1 K | Renaissance Technologies Corp | 2025-06-30 | 410.3 K | Raffles Associates Lp | 2025-06-30 | 402.7 K | Penbrook Management Llc | 2025-06-30 | 386.6 K | Panagora Asset Management Inc | 2025-06-30 | 350.1 K | Bard Associates Inc | 2025-06-30 | 336.3 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 285.3 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 274.6 K | Blackrock Inc | 2025-06-30 | 4.8 M | Forager Capital Management, Llc | 2025-06-30 | 2.1 M |
Viemed Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0649 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 343 M | ||||
| Shares Outstanding | 38.02 M | ||||
| Shares Owned By Insiders | 14.18 % | ||||
| Shares Owned By Institutions | 65.70 % | ||||
| Number Of Shares Shorted | 358.19 K | ||||
| Price To Earning | 29.88 X | ||||
| Price To Book | 2.47 X | ||||
| Price To Sales | 1.29 X | ||||
| Revenue | 224.26 M | ||||
| Gross Profit | 147.49 M | ||||
| EBITDA | 42.31 M | ||||
| Net Income | 11.41 M | ||||
| Cash And Equivalents | 21.92 M | ||||
| Cash Per Share | 0.57 X | ||||
| Total Debt | 6.87 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.34 X | ||||
| Book Value Per Share | 3.51 X | ||||
| Cash Flow From Operations | 39.09 M | ||||
| Short Ratio | 2.57 X | ||||
| Earnings Per Share | 0.34 X | ||||
| Target Price | 13.0 | ||||
| Number Of Employees | 1.38 K | ||||
| Beta | 1.26 | ||||
| Market Capitalization | 327.74 M | ||||
| Total Asset | 177.07 M | ||||
| Retained Earnings | 89.69 M | ||||
| Working Capital | 15.55 M | ||||
| Net Asset | 177.07 M |
About Viemed Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viemed Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viemed Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viemed Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:Check out For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Health Care Equipment & Supplies sector continue expanding? Could Viemed diversify its offerings? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Viemed Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.1) | Earnings Share 0.34 | Revenue Per Share | Quarterly Revenue Growth 0.24 | Return On Assets |
Viemed Healthcare's market price often diverges from its book value, the accounting figure shown on Viemed's balance sheet. Smart investors calculate Viemed Healthcare's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Viemed Healthcare's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.